Related Experiment Video

Updated: Oct 6, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Medial temporal lobe metabolic impairment in dementia associated with motor neuron disease

G Garraux1, E Salmon, C Degueldre

  • 1Cyclotron Research Center, Sart Tilman B30, B-4000, Liège, Belgium. garraux@pet.crc.ulg.ac.be

Journal of the Neurological Sciences
|October 20, 1999
PubMed

Insights

Patients with frontotemporal dementia (FTD) and FTD-motor neuron disease (FTD-MND) show similar frontal and temporal hypometabolism. However, FTD-MND patients exhibit greater impairment in medial temporal lobe activity, suggesting a functional continuum.

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Imaging

Background:

  • Frontotemporal dementia (FTD) can present with motor neuron disease features (FTD-MND).
  • Previous studies suggest functional similarities between FTD and FTD-MND, but neuropathology indicates greater medial temporal involvement in FTD-MND.
  • Understanding the metabolic patterns in FTD and FTD-MND is crucial for differentiating these conditions and understanding their relationship.

Purpose of the Study:

  • To compare the metabolic patterns in patients with FTD and FTD-MND using positron emission tomography (PET).
  • To investigate the extent of hypometabolism in medial temporal regions in FTD-MND compared to FTD.
  • To explore the hypothesis of a functional continuum between classical motor neuron disease (cMND), FTD-MND, and FTD.

Main Methods:

  • Positron emission tomography (PET) was used to measure regional glucose metabolism at rest.
  • Statistical parametric mapping (SPM96) was employed to compare metabolic data.
  • Ten FTD patients, three FTD-MND patients, and 46 healthy subjects (HS) were included in the study.

Main Results:

  • Both FTD and FTD-MND groups showed significant frontal and anterior temporal hypometabolism compared to HS.
  • FTD-MND patients exhibited significantly greater hypometabolism in the bilateral amygdala, hippocampus, and entorhinal/parahippocampal regions compared to FTD patients.
  • No significant differences in regional glucose uptake were found when directly contrasting FTD patients with FTD-MND patients in all regions.

Conclusions:

  • FTD and FTD-MND share comparable frontal and lateral temporal hypometabolism.
  • FTD-MND is characterized by a more pronounced impairment of medial temporal lobe activity.
  • The findings support a functional continuum linking cMND, FTD-MND, and FTD.

More Related Videos

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice07:03

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...